Tigatuzumab Biosimilar: Harnessing DR5 for Targeted Cancer Therapy Tigatuzumab is a monoclonal antibody targeting death receptor 5 (DR5), a member of the … read more 17th Dec 2025 Shanza Riaz
Alemtuzumab Biosimilar: Advancing CD52-Targeted Therapy Alemtuzumab is a monoclonal antibody targeting CD52, a glycoprotein highly expressed on … read more 17th Dec 2025
Enavatuzumab Biosimilar: Advancing TWEAKR-Targeted Therapy in Cancer Enavatuzumab is a monoclonal antibody targeting TWEAK receptor (TWEAKR, also known as F … read more 17th Dec 2025
Description Description Product Coming SoonIf you have a question, please don't hesitate to get in touch!
Choose Options Quick view Annexin V-AF488 Reagent MSRP: Now: $251 - $359 Was: Product Code: AKES025 Detection Method: Fluorometric Method
Choose Options Quick view Annexin V-AF488/PI Apoptosis Kit MSRP: Now: $191 - $287 Was: Product Code: AKES050 Detection Method: Fluorometric Instrument: Flow Cytometer